Nitric oxide in children with persistent asthma

Nulma S Jentzsch1, Muriel le Bourgeois, Jacques de Blic

  • 1Faculdade de Ciências Médicas de Minas Gerais, Belo Horizonte, MG, Brasil.

Jornal De Pediatria
|May 10, 2006
PubMed

Insights

Exhaled nitric oxide levels are higher in atopic asthma patients, indicating underlying inflammation despite clinical stability. This suggests atopic asthma may require closer monitoring for inflammation control.

Area of Science:

  • Pediatric Allergy and Immunology
  • Respiratory Medicine
  • Clinical Diagnostics

Background:

  • Asthma management often relies on clinical symptoms and lung function tests.
  • Atopic individuals exhibit heightened immune responses, potentially influencing asthma severity and treatment response.
  • Exhaled nitric oxide (FeNO) is a non-invasive biomarker of airway inflammation.

Purpose of the Study:

  • To compare exhaled nitric oxide (FeNO) levels between atopic and non-atopic asthmatic children on anti-inflammatory drugs.
  • To evaluate the correlation between FeNO measurements and standard lung function tests in pediatric asthma.

Main Methods:

  • A cross-sectional study involving 45 children (6-17 years) with persistent asthma on anti-inflammatory therapy.
  • Patients were categorized into atopic (positive skin tests) and non-atopic groups.
  • Concomitant assessment of clinical symptoms, lung function (FEV1, FEV1/FVC, FEF25-75%), and FeNO levels.

Main Results:

  • Atopic patients showed significantly higher FeNO levels (p < 0.001) and a higher frequency of eczema (p < 0.005).
  • No significant differences were observed in asthma symptoms, allergic rhinitis, food allergy, or need for systemic corticosteroids between groups.
  • Lung function parameters (FEV1, FEV1/FVC, FEF25-75%) did not significantly differ between atopic and non-atopic asthmatic children.

Conclusions:

  • Elevated FeNO in atopic asthmatic children suggests persistent airway inflammation not fully captured by clinical or lung function assessments.
  • Clinical and functional stability in atopic asthma may mask underlying inflammation, potentially increasing relapse risk after therapy cessation.
  • FeNO measurement offers valuable insights into airway inflammation in pediatric asthma, complementing traditional diagnostic tools.
Abstract

Related Concept Videos

Nitric Oxide Signaling Pathway01:28

Nitric Oxide Signaling Pathway

Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure to...
Asthma III: Clinical Manifestations01:13

Asthma III: Clinical Manifestations

Asthma presents with a characteristic pattern of episodic respiratory symptoms that reflect underlying airway inflammation, bronchoconstriction, and mucus hypersecretion. Although severity varies among individuals, certain clinical manifestations are considered hallmarks of the disorder and often guide diagnosis and assessment.Respiratory SymptomsA persistent cough is one of the most common early features of asthma. It is frequently dry and tends to worsen at night or in the early morning,...
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Asthma I: Introduction01:28

Asthma I: Introduction

Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes: